Aspects of risk stratification in acute coronary syndrome: Prognostic value of evaluation of left ventricular myocardial viability according to the data of pharmacological stress echocardiography


Aim. To define the prognostic value of the indicators of left ventricular myocardial viability according to the data of pharmacological stress echocardiography in patients with acute coronary syndrome (ACS). Materials and methods. The results of examinations were analyzed in a total of 91 patients with ACS; 71 of them were found to have areas of asynergy (these cases formed the key basis for statistical processing). An analysis of the outcomes registered in the established follow-up period (mean 14.3±0.7 months) took into consideration death from cardiac diseases, a recurrent acute coronary episode (nonfatal myocardial infarction (MI), unstable angina (UA)). Results. Risk stratification for cardiac events in patients with ACS requires both the assessment of a myocardial viability testing result and the detection of stress-induced ischemia. An analysis of the impact of the indicators of myocardial viability on prognosis in the ACS group showed that the most important predictors of cardiac death were impaired segmental contractility index (ISCI), number of asynergic segments, and total ejection fraction (TEF) at rest; TEF, ISCI, number of segments with a negative response to low-dose drug infusion; TEF, ΔTEF (as compared to the baseline data), and a positive or negative peak stress testing result. The most important predictors of major cardiac events (death MI, UA) were ascertained to be ISCI, number of asynergic segments, resting TEF; TEF, ISCI, number of segments with a negative response to low-dose drug infusion; a positive or negative testing result, TEF, ΔTEF (as compared to the baseline data), and ISCI during the peak stress test. Conclusion. The low myocardial/coronary reserve increases mortality rates; the high one worsens the prognosis of major cardiac events, particularly when the test is positive, which tacitly transfers these patients to a very high risk group.

Full Text

Restricted Access

About the authors

V A Gukasian

S T Matskeplishvili

V I Ioshina

M A Aripov

L S Shakhnazarian

É U Asymbekova

E V Zhertovskaia

Iu I Buziashvili


  1. Chua T. Myocardial viability: strengthening the evidence base. Eur J Nucl Med Mol Imag 2008; 35 (11): 2035-2037.
  2. Sicari R., Nihoyannopoulos P., Evangelista A. et al. European Association of Echocardiography. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr 2009; 30 (3): 278-289.
  3. Khumri T., Reid K., Kosiborod M. et al. Usefulness of left ventricular diastolic dysfunction as a predictor of one-year rehospitalization in survivors of acute myocardial infarction. Am J Cardiol 2009; 103 (1): 17-21.
  4. Møller J., Hillis G., Oh J. et al. Wall motion score index and ejection fraction for risk stratification after acute myocardial infarction. Am Heart J 2006; 151 (2): 419-425.
  5. Zhang Y., Yip G., Chan A. et al. Left ventricular systolic dyssynchrony is a predictor of cardiac remodeling after myocardial infarction. Am Heart J 2008; 156 (6): 1124-1132.
  6. Mieres J., Makaryus A., Redberg R., Shaw L. Noninvasive cardiac imaging. Am Fam Physician 2007; 75 (8): 1219-1228.
  7. Picano E., Lombardi M., Neglia D., Lazzeri M. Sustainability of medical imaging in cardiology. Recenti Prog Med 2006; 97 (11): 652-662.
  8. Anderson J., Adams C., Antman E. et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction). Circulation 2007; 116 (7): e148-е304.
  9. Bassand J., Hamm C., Ardissino D. et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007; 28 (13): 1598-1660.
  10. Schiller N., Shah P., Crawford M. et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2 (5): 358-367.
  11. Elmariah S., Smith S.-Jr., Fuster V. Late medical versus interventional therapy for stable ST-segment elevation myocardial infarction. Nat Clin Pract Cardiovasc Med.2008; 5 (1): 42-52.
  12. Михеев Н.Н. Осложнения стресс-эхокардиографии при диагностике ишемической болезни сердца. Кардиология 2008; 1: 19-23.
  13. Varga A., Garcia M., Picano E. International Stress Echo Complication Registry. Safety of stress echocardiography (from the International Stress Echo Complication Registry). Am J Cardiol 2006; 98 (4): 541-543.
  14. Fox K., Garcia M., Ardissino D. et al. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006; 27 (11): 1341-1381.
  15. Nedeljkovic I., Ostojic M., Beleslin B. et al. Comparison of exercise, dobutamine-atropine and dipyridamole-atropine stress echocardiography in detecting coronary artery disease. Cardiovasc Ultrasound 2006; 4: 22.
  16. Picano E., Molinaro S., Pasanisi E. The diagnostic accuracy of pharmacological stress echocardiography for the assessment of coronary artery disease: a meta-analysis. Cardiovasc Ultrasound 2008; 6: 30.
  17. Sicari R., Picano E., Landi P. et al. Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. Echo Dobutamine International Cooperative (EDIC) Study. J Am Coll Cardiol 1997; 29 (2): 254-260.
  18. Picano E., Sicari R., Landi P. et al. Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: a dobutamine stress echocardiographic study. Circulation 1998; 98 (11): 1078-1084.
  19. Tio R., Dabeshlim A., Siebelink H. et al. Comparison Between the Prognostic Value of Left Ventricular Function and Myocardial Perfusion Reserve in Patients with Ischemic Heart Disease. J Nucl Med 2009; 50 (2): 214-219.
  20. Carlos M., Smart S., Wynsen J., Sagar K. Dobutamine stress echocardiography for risk stratification after myocardial infarction. Circulation 1997; 95 (6): 1402-1410.
  21. Cortigiani L., Sicari R., Bigi R. et al. Usefulness of stress echocardiography for risk stratification of patients after percutaneous coronary intervention. Am J Cardiol 2008; 102 (9): 1170-1174.
  22. Fox K., Anderson F.-Jr., Dabbous O. et al. GRACE investigators. Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE). Heart 2007; 93 (2): 177-182.
  23. Taneja A., Collinson J., Flather M. et al. Mortality following non-ST elevation acute coronary syndrome: 4 years follow-up of the PRAIS UK Registry (Prospective Registry of Acute Ischaemic Syndromes in the UK). Eur Heart J 2004; 25 (22): 2013-2018.
  24. Mauro V., Cianciulli T., Prezioso H. et al. Dobutamine stress echocardiography can predict reversible ventricular dysfunction after acute myocardial infarction. Clin Cardiol 2005; 28 (11): 523-528.
  25. Асымбекова Э.У. Диагностика и тактика лечения больных ИБС с обратимыми формами дисфункции миокарда левого желудочка: Автореф. дис. ... д-ра мед. наук. М 1999.
  26. Мацкеплишвили С.Т. Стресс-эхокардиография в диагностике ишемической болезни сердца, определении прогноза и оценке результатов хирургического и эндоваскулярного лечения: Автореф. дис. ... д-ра мед. наук. М 2002
  27. Volpi A., De Vita C., Franzosi M. et al. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base. Circulation 1993; 88 (2): 416-429.
  28. Арипов М.А. Возможности лечения острого коронарного синдрома в условиях кардиохирургического стационара: Автореф. дис. ... д-ра мед. наук. М 2005.



Abstract - 23



  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Novoslobodskaya str 31c4., Moscow, 127005, Russian Federation

Managing Editor:


© 2018 "Consilium Medicum" Publishing house

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies